Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPS immunization followed by mosquito or blood-stage malaria challenge
NL-OMON36473Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2011
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of chloroquine, atovaquone + proguanil and Plasmodium falciparum sporozoites in malaria and Falciparum malaria (PF) (4 arms), sponsored by Radboud University Medical Center. Primary endpoints: Duration of prepatent period, Parasitemia and parasitemia kinetics and 1 more. Started Apr 2011; status: active, not recruiting.
02
Drugs
chloroquineatovaquone + proguanilPlasmodium falciparum sporozoites
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on NL-OMON36473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36473.